Sergio Santillana

Entity
Individual
Business address
Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, 02139 Cambridge, MA
Signature Ownership
/s/ Mark Manfredi, as Attorney-in-Fact for Sergio Santillana
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Sergio Santillana has filed 8 SEC EDGAR filings since 6/15/2017

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 SUBMISSION Jan 5, 2023 Jan 3, 2023 001-40287
4 Open Document Open Filing FORM 4 SUBMISSION Feb 4, 2022 Feb 2, 2022 001-40287
3/A Open Document Open Filing FORM 3/A SUBMISSION Mar 30, 2021 Mar 25, 2021 001-40287
3 Open Document Open Filing FORM 3 SUBMISSION Mar 25, 2021 Mar 25, 2021 001-40287
4 Open Document Open Filing FORM 4 SUBMISSION Dec 13, 2018 Dec 11, 2018 001-35409
4 Open Document Open Filing FORM 4 SUBMISSION Feb 16, 2018 Feb 15, 2018 001-35409
4 Open Document Open Filing FORM 4 SUBMISSION Jun 15, 2017 Jun 13, 2017 001-35409
3 Open Document Open Filing FORM 3 SUBMISSION Jun 15, 2017 Jun 12, 2017 001-35409